CBT
GSK icon

Central Bank & Trust’s GSK GSK Stock Holding History

Central Bank & Trust’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-80
Closed -$4K – 269
2019
Q1 		$4K Hold
80
– – ﹤0.01% 253
2018
Q4 		$4K Hold
80
– – ﹤0.01% 251
2018
Q3 		$4K Sell
80
-322
-80% -$16.4K ﹤0.01% 256
2018
Q2 		$20K Buy
+402
New +$20.2K 0.01% 202

Other funds holding GSK

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BCIM
Black Creek Investment Management Toronto, Ontario, Canada $1.86B AUM 15.33% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Hotchkis & Wiley Capital Management
Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return

Central Bank & Trust's GSK Position: Q2 2019 in Review

Central Bank & Trust sold out of GSK (GSK) in Q2 2019, closing a stake of 80 shares — an estimated $4K sold.

Central Bank & Trust first reported a position in GSK in Q2 2018 and held it in 4 quarters. The position peaked at $20K in Q2 2018. 804 funds tracked by Wall St. Rank hold GSK as of Q2 2019.

  • Central Bank & Trust reported no remaining GSK position as of Q2 2019 after selling out during the quarter.
  • Central Bank & Trust sold 80 GSK shares in Q2 2019, an estimated $4K.
  • Central Bank & Trust first reported a position in GSK in Q2 2018 and held it in 4 quarters.
  • Central Bank & Trust's GSK position peaked at $20K in Q2 2018.
  • 804 funds tracked by Wall St. Rank held GSK as of Q2 2019.

Based on Central Bank & Trust's 13F filing for Q2 2019, filed 16 Jul 2019.